Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Quinti

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Journal of Clinical Immunology|September 21, 2011
Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter studyMichael Borte, Isabella Quinti, Annarosa Soresina, et al.
Scandinavian Journal of Immunology|August 9, 2020
IgM, IgA and IgG response to conjugate polysaccharides in children with recurrent respiratory infectionsFilomena Monica Cavaliere, Simona Graziani, Elisabetta Del Duca, et al.
Journal of Clinical Immunology|July 23, 2014
Adequate patient's outcome achieved with short immunoglobulin replacement intervals in severe antibody deficienciesCinzia Milito, Federica Pulvirenti, Anna Maria Pesce, et al.
Immunologic Research|November 20, 2014
Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cellsMilica Mitrevski, Ramona Marrapodi, Alessandro Camponeschi, et al.
Journal of Innate Immunity|August 8, 2024
Dysregulation of Toll-Like Receptor Signaling-Associated Gene Expression in X-Linked Agammaglobulinemia: Implications for Correlations Genotype-Phenotype and Disease ExpressionMarcelo Teocchi, Thaís de Andrade Eugênio, Lia Furlaneto Marega, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 2002
European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countriesIsabella Quinti, Marina Pierdominici, Marco Marziali, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 4, 2016
Otologic evaluation of patients with primary antibody deficiencyGiuseppe Magliulo, Giannicola Iannella, Guido Granata, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2005
The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiencyRita Carsetti, Maria Manuela Rosado, Simona Donnanno, et al.
Journal of Immunology Research|April 18, 2014
Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficienciesFederica Pulvirenti, Ilaria Pentassuglio, Cinzia Milito, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 24, 2019
Health-Related Quality of Life in Children and Adults with Primary Immunodeficiencies: A Systematic Review and Meta-AnalysisDmitrii Peshko, Ekaterina Kulbachinskaya, Ilya Korsunskiy, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Journal of Clinical Immunology|September 21, 2011
Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter studyMichael Borte, Isabella Quinti, Annarosa Soresina, et al.
Scandinavian Journal of Immunology|August 9, 2020
IgM, IgA and IgG response to conjugate polysaccharides in children with recurrent respiratory infectionsFilomena Monica Cavaliere, Simona Graziani, Elisabetta Del Duca, et al.
Journal of Clinical Immunology|July 23, 2014
Adequate patient's outcome achieved with short immunoglobulin replacement intervals in severe antibody deficienciesCinzia Milito, Federica Pulvirenti, Anna Maria Pesce, et al.
Immunologic Research|November 20, 2014
Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cellsMilica Mitrevski, Ramona Marrapodi, Alessandro Camponeschi, et al.
Journal of Innate Immunity|August 8, 2024
Dysregulation of Toll-Like Receptor Signaling-Associated Gene Expression in X-Linked Agammaglobulinemia: Implications for Correlations Genotype-Phenotype and Disease ExpressionMarcelo Teocchi, Thaís de Andrade Eugênio, Lia Furlaneto Marega, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 2002
European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countriesIsabella Quinti, Marina Pierdominici, Marco Marziali, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 4, 2016
Otologic evaluation of patients with primary antibody deficiencyGiuseppe Magliulo, Giannicola Iannella, Guido Granata, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2005
The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiencyRita Carsetti, Maria Manuela Rosado, Simona Donnanno, et al.
Journal of Immunology Research|April 18, 2014
Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficienciesFederica Pulvirenti, Ilaria Pentassuglio, Cinzia Milito, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 24, 2019
Health-Related Quality of Life in Children and Adults with Primary Immunodeficiencies: A Systematic Review and Meta-AnalysisDmitrii Peshko, Ekaterina Kulbachinskaya, Ilya Korsunskiy, et al.
Pageof 15